Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Patients With Atopic Dermatitis

NCT00666302 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00666302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00666302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Patients With Atopic Dermatitis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2002
Completion date
November 30, 2003
Enrollment
413 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, atopic